All Articles

CEO Joe Hayek will outline a strategy of M&A and innovation to boost value as the company navigates a complex market. Here’s what to expect.

A major HUD loan sale puts 2,500 occupied homes in the balance, pitting investor profits against the fate of non-borrowing family members.

New system from Montrose tackles a major methane source, promising greater accuracy, technician safety, and faster action on climate goals.

The digital-native waterproof shoe brand Vessi opens its first U.S. store, blending online savvy with a physical footprint and community support.

A new mobile app from Reliance Matrix and AllOne Health uses an AI navigator to provide instant, personalized EAP support, aiming to boost low usage.

As Harmony Biosciences presents at JPM, investors will scrutinize its strategy for sustaining growth beyond its star drug and advancing its rare disease pipeline.

A new AI receptionist integrated into HawkSoft aims to end missed calls and manual data entry. But are independent agencies ready to trust the technology?

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

Instead of selling out, the family-owned natural products giant is making its 1,800 employees owners, securing a legacy of independence and community focus.

The deal creates an end-to-end commercialization powerhouse, tackling pharma's toughest payer, reimbursement, and patient affordability challenges.

With $16.4M in new funding, STRM.BIO is advancing a novel gene therapy platform that uses natural vesicles to target bone marrow, offering new hope for rare diseases.

Navan CEO Ariel Cohen will pitch his growth strategy at the Needham conference, a key test for the travel tech firm amid stock declines and high hopes.

Palisade Bio's PALI-2108, a drug targeting IBD at its source, secures a key investment, offering hope for a new era of treatment with fewer side effects.

A new global study shows consumers embrace AI for product research but don't trust it for purchases, revealing a 'Confidence Economy' ruled by transparency.

Blackstone is now the sole institutional backer of AIR Control Concepts, fueling the HVAC leader's rapid growth and strategic expansion into the booming data center market.

Formerly Pure Harvest, Mixie Technologies acquires a stake in digital twin firm HoloTwin, signaling a major strategic shift into AI and platform solutions.

Health tech firm IMVARIA, maker of an FDA-authorized AI for lung disease, has secured strategic funding from InHealth Ventures and Labcorp to expand its reach.

A new partnership brings a complex wealth-building insurance product to the digital age, offering instant decisions and no medical exams. Is this the future?

A new tri-specific antibody, IM1240, safely hits cancer cells at massive doses in preclinical studies, potentially solving a key toxicity problem in immunotherapy.

A new partnership gives NWS forecasters unprecedented views into weather blind spots, boosting warning capabilities for 130 million Americans.